Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.

Boursi B, Sella T, Liberman E, Shapira S, David M, Kazanov D, Arber N, Kraus S.

Eur J Cancer. 2013 Nov;49(17):3680-5. doi: 10.1016/j.ejca.2013.06.040. Epub 2013 Jul 26.

PMID:
23896379
2.

The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.

Strul H, Barenboim E, Leshno M, Gartner M, Kariv R, Aljadeff E, Aljadeff Y, Kazanov D, Strier L, Keidar A, Knaani Y, Degani Y, Alon-Baron L, Sobol-Dvory H, Halpern Z, Arber N.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1012-5.

3.

Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.

Rozen P, Naiman T, Strul H, Taussky P, Karminsky N, Shomrat R, Samuel Z, Yaron Y, Orr-Urtreger A.

Cancer. 2002 May 15;94(10):2561-8.

4.

APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews.

Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, Serfas K, Blumenthall A, Dewar D, Baumann E, Lagarde AE.

Gastroenterology. 2001 Feb;120(2):392-400.

PMID:
11159880
5.

Colorectal polyps in carriers of the APC I1307K polymorphism.

Rennert G, Almog R, Tomsho LP, Low M, Pinchev M, Chaiter Y, Bonner JD, Rennert HS, Greenson JK, Gruber SB.

Dis Colon Rectum. 2005 Dec;48(12):2317-21.

PMID:
16228836
6.

Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.

Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, Legum C, Orr-Urtreger A.

Gastroenterology. 1999 Jan;116(1):54-7.

PMID:
9869602
7.

The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.

Locker GY, Kaul K, Weinberg DS, Gatalica Z, Gong G, Peterman A, Lynch J, Klatzco L, Olopade OI, Bomzer CA, Newlin A, Keenan E, Tajuddin M, Knezetic J, Coronel S, Lynch HT.

Cancer Genet Cytogenet. 2006 Aug;169(1):33-8.

PMID:
16875934
8.

Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.

Drucker L, Shpilberg O, Neumann A, Shapira J, Stackievicz R, Beyth Y, Yarkoni S.

Cancer. 2000 Feb 15;88(4):755-60.

PMID:
10679643
9.

The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.

Shtoyerman-Chen R, Friedman E, Figer A, Carmel M, Patael Y, Rath P, Fidder HH, Bar-Meir S, Theodor L.

Genet Test. 2001 Summer;5(2):141-6.

PMID:
11551102
10.

Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.

Syngal S, Schrag D, Falchuk M, Tung N, Farraye FA, Chung D, Wright M, Whetsell A, Miller G, Garber JE.

JAMA. 2000 Aug 16;284(7):857-60.

PMID:
10938175
11.

Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.

Zauber NP, Sabbath-Solitare M, Marotta S, Zauber AG, Foulkes W, Chan M, Turner F, Bishop DT.

Cancer. 2005 Aug 15;104(4):719-29.

12.

Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.

Silverberg MS, Clelland C, Murphy JE, Steinhart AH, McLeod RS, Greenberg GR, Cohen Z, Siminovitch KA.

Hum Genet. 2001 Mar;108(3):205-10.

PMID:
11354631
13.

The I1307K polymorphism of the APC gene in colorectal cancer.

Prior TW, Chadwick RB, Papp AC, Arcot AN, Isa AM, Pearl DK, Stemmermann G, Percesepe A, Loukola A, Aaltonen LA, De La Chapelle A.

Gastroenterology. 1999 Jan;116(1):58-63.

PMID:
9869603
14.

How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.

Dundar M, Caglayan AO, Saatci C, Karaca H, Baskol M, Tahiri S, Ozkul Y.

Cancer Genet Cytogenet. 2007 Sep;177(2):95-7.

PMID:
17854661
15.

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.

Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, Ben David Y, Biran H, Fields A, Brunet JS, Narod SA.

Cancer Res. 1998 Jul 15;58(14):2919-22.

16.

Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.

Niell BL, Long JC, Rennert G, Gruber SB.

Am J Hum Genet. 2003 Dec;73(6):1250-60. Epub 2003 Nov 17.

17.
18.

The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.

Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK.

Cancer Res. 1997 Dec 15;57(24):5480-4.

19.

Genetic factors and colorectal cancer in Ashkenazi Jews.

Locker GY, Lynch HT.

Fam Cancer. 2004;3(3-4):215-21. Review.

PMID:
15516844
20.

Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant.

Hall MJ, Liberman E, Dulkart O, Galazan L, Sagiv E, Shmueli E, Kazanov D, Hallak A, Moshkowitz M, Figer A, Kraus S, Inbar M, Neugut AI, Arber N.

Ann Oncol. 2009 Sep;20(9):1517-21. doi: 10.1093/annonc/mdp023. Epub 2009 May 27.

Items per page

Supplemental Content

Write to the Help Desk